ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Aclarion, Inc. (ACON) stock surged +11.49%, trading at $12.61 on NASDAQ, up from the previous close of $11.31. The stock opened at $11.06, fluctuating between $11.06 and $13.69 in the recent session.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Employees | 4 |
Beta | 0.47 |
Sales or Revenue | $75.40K |
5Y Sales Change% | -0.715% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Medical - Healthcare Information Services |